Abstract
Before an agent can damage a cancer cell, it must be able to pass through the outer cell membrane, also called the plasma membrane. An exception to this rule would be provided by a “membrane-active” compound, which would affect the plasma membrane only and by so doing cause cell death. Antibacterial agents of this type do exist (Hamilton, 1970). One may speculate that highly lipid soluble compounds could be localized in plasma membranes of mammalian cells and thereby seriously alter cellular metabolism. However, most of the antineoplastic agents whose mode of action is understood appear to act somewhere within the cell. A notable exception is provided by asparaginase, which, without entering the cells, causes a critical deficiency of asparagine by cleaving it extracellularly to aspartic acid (Broome, 1968; Suolinna et al., 1971).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Askari, A.: Uptake of some quaternary ammonium ions by human erythrocytes. J. gen. Physiol. 49, 1147–1160 (1966).
Ballard, P.L., Tomkins, G.M.: Hormone induced modification of the cell surface. Nature (Lond.) 224, 344–345 (1969).
Benedetti, E.L., Emmelot, P.: Structure and function of plasma membranes isolated from liver. In: Dalton, A. J., Haguenau, F. (Eds.): Ultrastructure in biological systems, vol. 4, The Membranes, pp. 33–120. New York: Academic Press (1968).
Bennett, L.L., Jr.: Phthalanilides and some related dibasic and polybasic compounds: A review of biological activities and modes of action. Progr. exp. Tumor Res. 7, 259–325 (1965).
Bensch, K.G., Simbonis, S., Hill, R.B., King, D.W.: Phagocytosis and cell division. Nature (Lond.) 183, 476–477 (1959).
Ber, R., Griffin, M.J.: Location of hydrocortisone in dividing Hela S3 cells. Fed. Proc. 26, 616 (1967).
Bieber, A.L., Sartorelli, A.C.: The metabolism of thioguanine in purine analog resistant cells. Cancer Res. 24, 1210–1215 (1964).
Blair, D.G.R., Hebert, G.J.: Uptake of 2, 6-diaminopurine-2-C14 by 2, 6-DAP-sensitive and-resistant L strain mouse cells grown on plastic discs. Canad. J. Physiol. Pharmacol. 48, 791–800 (1970).
Bobinski, H., Stein, W.D.: Isolation of a glucose-binding component from human erythrocyte membranes. Nature (Lond.) 211, 1366–1368 (1966).
Bobzien, W., Goldman, I.D.: The mechanism of methotrexate transport in rabbit reticulocytes. J. clin. Invest. 51, 1688–1696 (1972).
Booij, H.L., Bungenberg De Jong, H.G.: Biocolloids and their interactions. Proto-plasmatologia I 2, 142. Springer: Wien 1956.
Braganca, B.M., Divekar, A.Y., Vaidya, N.R.: Defective transport of aminopterin in relation to development of resistance in Yoshida sarcoma cells. Biochim. biophys. Acta (Amst.) 135, 937–946 (1967).
Broome, J.D.: Studies on the mechanism of tumor inhibition by L-asparaginase. J. exp. Med. 127, 1055–1072 (1968).
Bucknall, R.M., Carter, S.B.: A reversible inhibitor of nucleic acid synthesis. Nature (Lond.) 213, 1099–1101 (1967).
Collins, F.D., Roberts, W.K.: The effect of dimethvl sulfoxide on nucleoside transport in L-cells. Biochim. biophys. Acta (Amst.) 233, 459–464 (1971).
Dave, C., Caballes, L.: Studies on the uptake of methylglyoxal-bis(guanylhydrazone) and spermidine in mouse leukemia L1210 sensitive and resistant to CH3-G. Fed. Proc. 32, 736 (1973).
Dave, C., Mihich, E.: Uptake and intracellular distribution of 4, 4′-diacetyldiphenylurea-bis-(guanylhydrazone) in sensitive and resistant leukemia L1210 cells. Biochem. Pharmacol. 21, 2681–2695 (1972).
Dave, C., Ehrke, J., Soucek, J., Mihich, E.: Differences in the action of methylglyoxal-bis-guanylhydrazone, 4, 4,4′-diacetyl-diphenyl-urea-6¿5-guanylhydrazone and related analogs. Fed. Proc. 30, 628 (1971).
Davidson, J.R.: Permeability of resistant L1210 leukemia cells to 8-azaguanine and 6-mer-captopurine. Proc. Amer. Ass. Cancer Res. 2, 290 (1958).
Dewey, M.M., Barr, L.: Some considerations about the structure of cellular membranes. In: Bonner, F., Kleinzeller, A. (Eds.): Current topics in membrane transport, vol. 1, pp. 1–33. New York: Academic Press 1970.
Diamond, I., Kennedy, E.P.: Carrier-mediated transport of choline into synaptic nerve endings. J. biol. Chem. 244, 258–3263 (1969).
Divekar, A.Y., Fleysher, M.H., Slocum, H.K., Kenny, L.N., Hakala, M.T.: Changes in Sarcoma 180 cells associated with drug-induced resistance to adenosine analogs. Cancer Res. 32, 2530–2537 (1972).
Divekar, A.Y., Vaidya, N.R., Braganca, B.M.: Active transport of aminopterin in Yoshida sarcoma cells. Biochim. biophys. Acta (Amst.) 135, 927–936 (1967).
Dourmashkin, R.R., Dougherty, R.M.: Phagocytosis of crystalline particles by cells grown in tissue culture. Exp. Cell Res. 25, 480–484 (1961).
DuBuy, H.G., Showacre, J.L.: Selective localization of tetracycline in mitochondria of living cells. Science 133, 196–197 (1961).
Emmelot, P., Bos, C.J.: Studies on plasma membranes. I. Chemical composition and enzyme content of plasma membranes from rat liver. Biochim. biophys. Acta (Amst.) 90, 126–145 (1966).
Field, M., Block, J.B., Oliverio, V.T., Rall, D.P.: Cellular accumulation of methylglyoxal-bis-guanylhydrazone in vitro. I. General characteristics of cellular uptake. Cancer Res. 24, 1939–1946 (1964).
Fischer, G.A.: Defective transport of amethopterin as a mechanism of resistance to the antimetabolite. Biochem. Pharmacol. 11, 1233–1237 (1962).
Folca, P.J., Glascock, R.F., Irvine, W.T.: Studies with tritium-labeled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy. Lancet 2, 796–798 (1961).
Gentry, G.A., Morse, P.A., Ives, D.H., Gebert, R., Potter, V.R.: Pyrimidine metabolism in tissue culture cells derived from rat hepatomas. II. Thymidine uptake in suspension cultures derived from Novikoff hepatomas. Cancer Res. 25, 509–516 (1965).
Giannopoulos, G., Gorski, J.: Estrogen receptors. Quantitative studies on transfer of estradiol from cytoplasmic to nuclear binding sites. J. biol. Chem. 246, 2524–2529 (1971a).
Giannopoulos, G., Gorski, J.: Estrogen-binding protein of the rat uterus. Different molecular forms associated with nuclear uptake of estradiol. J. biol. Chem. 246, 2530–2536 (1971b).
Goldenberg, G. J., Vanstone, C.L., Bihler, L.: Transport of nitrogen mustard on the transport carrier for choline in L5178Y lymphoblasts. Science 172, 1148–1149 (1971).
Goldenberg, G.J., Vanstone, C.L., Israels, L.G., Ilse, D., Bihler, L.: Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178 Y lymphoblasts. Cancer Ees. 30, 2285–2291 (1970).
Goldman, I.D.: Transport energetics of the folic acid analog, methotrexate, in L1210 leukemia cells. J. biol. Chem. 244, 3779–3785 (1969).
Goldman, I.D.: The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann. N. Y. Acad. Sci. 186, 400–422 (1971a).
Goldman, I.D.: A model system for the study of heteroexchange diffusion: methotrexate- folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. Biochim. biophys. Acta (Amst.) 233, 624–634 (1971b).
Goldman, I.D., Lichtenstein, N.S., Oliverio, V.T.: Carrier transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J. biol. Chem. 243, 5007–5017 (1968).
Graham, J.M., Green, C.: The binding of hormones and related compounds by normal and cholesterol-depleted plasma membranes of rat liver. Biochem. Pharmacol. 18, 493–502 (1969).
Grindey, G., Nichol, C.A.: Interaction of drugs inhibiting different steps in the synthesis of DNA. Cancer Res. 32, 527–531 (1972).
Haeala, M.T.: On the role of drug penetration in amethopterin resistance of S-180 cells in vitro. Biochim. biophys. Acta (Amst.) 102, 198–209 (1965a).
Hakala, M.T.: On the nature of permeability of S-180 cells to amethopterin in vitro. Biochim. biophys. Acta (Amst.) 102, 210–225 (1965b).
Hakala, M.T.: Biochemical basis of resistance to folic acid antagonists. PEBS Symp. 16, 31–47 (1969).
Hakala, M.T.: Uptake and distribution of 4, 4′-diacetyl-diphenyl-urea-bis-guanylhydrazone in sensitive and resistant Sarcoma 180 cells in vitro. Biochem. Pharmacol. 20, 81–95 (1971).
Hakala, M.T.: Enzyme changes in resistant tissues. In: Mihich, E. (Ed.): Drug resistance and selectivity: biochemical and cellular basis, pp. 263–298. New York: Academic Press 1973.
Hakala, M.T., Chheda, G.B., Kenny, L.N.: Kinetics and specificity of uptake of 8–14C-purine and 2–14C-pyrimidine nucleosides in Sarcoma 180 cells in vitro. Abstracts, Am. Chem. Soc. Meeting, Chicago, August 1973, Biol. No. 233 (1973).
Hakala, M.T., Kenny, L.N.: Common mechanism for the passage of purine and pyrimidine nucleosides through the plasma membrane of Sarcoma 180 cells. Fed. Proc. 31, 475 (1972).
Hakala, M.T., Kenny, L.N., Slocum, H.K.: Inhibition of adenosine uptake by N 6-(∆ 2-isopentenyl) adenosine and kinetin riboside. Fed. Proc. 30, 697 (1971).
Hakala, M.T., Suounna, E.M., Kenny, L.N., Tritsch, G.: Biochim. biophys. Acta (Amst.), in press.
Hall, T.C., Roberts, D., Kessel, D.: Methotrexate and folate reductase in human cancer. Europ. J. Cancer 2, 135–142 (1966).
Hamilton, W.A.: The mode of action of membrane-active antibacterials. Fed. Europ. biochem. Soc. 20, 71 (1970).
Hansen, P., Stein, H.: On the synthesis of RNA in lymphocytes stimulated by phyto-hemagglutinin. I. Induction of uridine kinase and the conversion of uridine to UTP. Europ. J. Biochem. 4, 401–406 (1968).
Harvey, A.M., Christensen, H.N.: Uric acid transport system. Apparent absence in erythrocytes of the Dalmatian coach hound. Science 145, 826–827 (1964).
Hawkins, R.A., Berlin, R.D.: Purine transport in polymorphonuclear leukocytes. Biochim. biophys. Acta (Amst.) 173, 324–337 (1969).
Heidrick, M.L., Ryan, W.L.: Cyclic nucleotides on cell growth in vitro. Cancer Res. 30, 376–378 (1970).
Henderson, E.S., Adamson, R.H., Oliverio, V.T.: The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. Cancer Res. 25, 1018–1024 (1965).
Ho, Y.K., Hakala, M.T., Zakrzewski, S.F.: 5-(l-Adamantyl)pyrimidines as inhibitors of folate metabolism. Cancer Res. 32, 1023–1028 (1972).
Hodgkin, A.L., Martin, K.: Choline uptake by giant axons of Loligo. J. Physiol. (Lond.) 179, 26P–27P (1965).
Hollander, N., Chiu, Y.W.: In vitro binding of Cortisol[1–2-H3] by a substance in the supernatant fraction of P1798 mouse lymphosarcoma. Biochem. biophys. Res. Comm. 25, 291–297 (1966).
Holmsen, H., Rozenberg, M.C.: Adenine nucleotide metabolism of blood platelets. I. Adenosine kinase and nucleotide formation from exogenous adenosine and AMP. Biochim. biophys. Acta (Amst.) 155, 326–341 (1968).
Holter, H.: Pinocytosis. Int. Rev. Cytol. 8, 481–504 (1959).
Jacquez, J.A.: Permeability of Ehrlich (ascites) cells to uracil, thymine, and fluorouracil. Proc. Soc. exp. Biol. (N.Y.) 109, 132–135 (1962a).
Jacquez, J.A.: Transport and enzymic splitting of pyrimidine nucleosides in Ehrlich cells. Biochim. biophys. Acta (Amst.) 61, 265–277 (1962b).
Jacquez, J.A.: Permeability of Ehrlich ascites cells to folic acid, aminopterin and amethopterin. Cancer Res. 26, 1616–1624 (1966).
Jacquez, J.A., Ginsberg, F.: Permeability of Ehrlich ascites cells to adenine. Proc. Soc. exp. Biol. (N. Y.) 105, 478–480 (1960).
Jost, J.P., Rickenberg, H.V.: Cyclic AMP. Ann. Rev. Biochem. 40, 741–774 (1971).
Kessel, D.: A comparison of 4-amino, N 10-methylpteroic acid and methotrexate transport by mouse leukemic cells. Molec. Pharmacol. 5, 21–25 (1969).
Kessel, D., Botterill, V., Hall, T.C.: Stimulation by pteridines of the uptake of amethopterin by human lymphocytes. Biochem. Pharmacol. 17, 1727–1733 (1968a).
Kessel, D., Bruns, R., Hall, T.C.: Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias. Molec. Pharmacol. 7, 117–121 (1971).
Kessel, D., Hall, T.C.: Studies on drug transport by normal human leukocytes. Biochem. Pharmacol. 16, 2395–2403 (1967a).
Kessel, D., Hall, T.C.: Amethopterin transport in Ehrlich ascites carcinoma and L1210 cells. Cancer Res. 27, 1539–1543 (1967b).
Kessel, D., Hall, T.C.: Effects of persantin on deoxycytidine transport by murine leukemia cells. Biochim. biophys. Acta (Amst.) 211, 88–94 (1970).
Kessel, D., Hall, T.C., Roberts, D.: Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res. 28, 564–570 (1968b).
Kessel, D., Hall, T.C., Roberts, D., Wodinsky, I.: Uptake as a determinant of amethopterin response in mouse leukemias. Science 150, 752–754 (1965).
Kessel, D., Myers, M., Wodinsky, I.: Accumulation of two alkylating agents, nitrogen mustard and busulfan, by murine leukemia cells in vitro. Biochem. Pharmacol. 18, 1229–1234 (1969).
Kessel, D., Shurin, S.B.: Transport of two non-metabolizable nucleosides, deoxycytidine and arabinosylcytosine in a subline of L1210 murine leukemia. Biochim. biophys. Acta (Amst.) 163, 179–187 (1968).
Kirkpatrick, A.F., Kaiser, N., Milholland, R. J., Rosen, F.: Glucocorticoid-binding macro-molecules in normal tissues and tumors. Stabilization of the specific binding component. J. biol. Chem. 247, 70–74 (1972).
Kotyk, A.: Present situation in the identification of membrane transport proteins of single cells. Fed. Europ. biochem. Soc. 20, 99–108 (1970).
Kreis, W., Wechter, W.J.: Biological activity of 3′, 5′-cyclic phosphates of l-β-D-arabino-furanosylcytosine (ara-C). Proc. Am. Ass. Cancer Res. 13, 62 (1972).
Kübler, W., Bretschneider, H.J.: Kompetitive Hemmung der katalysierten Adenosin-Diffusion als Mechanismus der coronarerweiternden Wirkung eines Pyrimidopyrimidin-Derivates. Arch. ges. Physiol. 280, 141–157 (1964).
Lassen, U.V.: Asymmetry of uric acid transport through the human erythrocyte membrane induced by hypoxanthine. Biochim. biophys. Acta (Amst.) 57, 123–129 (1962).
Lassen, U.V.: Hypoxanthine transport in human erythrocytes. Biochim. biophys. Acta (Amst.) 135, 146–154 (1967).
Lassen, U.V., Overgaard-Hansen, K.: Hypoxanthine as inhibitor of uric acid transport in human erythrocytes. Biochim. biophys. Acta (Amst.) 57, 111–117 (1962a).
Lassen, U.V., Overgaard-Hansen, K.: Purine derivatives as inhibitors of uric acid transport into human erythrocytes. Biochim. biophys. Acta (Amst.) 57, 118–122 (1962b).
Leibman, K.C., Heidelberger, C.: The metabolism of 32P-labeled ribonucleotides in tissue slices and cell suspensions. J. biol. Chem. 216, 823–830 (1955).
Lichtenstein, N.S., Goldman, I.D.: Riboflavin-methotrexate interactions. Photochemical reaction and competition for transport in the L1210 mouse leukemia cell. Biochem. Pharmacol. 19, 1229–1239 (1970).
Linford, J.H., Hryniuk, W., Israels, L.G.: Adsorption to human red blood cells of chlorambucil and other biological alkylating agents. Biochem. Pharmacol. 18, 2723–2735 (1969).
Loo, T.L., Wang-Ho, D.H., Blossom, D.H., Shepard, B.J., Frei, E. III: Cellular uptake of purine antimetabolites in vitro. I. Uptake of methylmercaptopurine riboside by human red blood cells. Biochem. Pharmacol. 18, 1711–1725 (1969).
Lowy, B.A., Williams, M.K.: Studies on the metabolism of adenosine and adenine in stored and fresh human erythrocytes. Blood 27, 623–628 (1966).
Lowy, B.A., Williams, M.K., London, I.M.: Enzymatic deficiencies of purine nucleotide synthesis in the human erythrocytes. J. biol. Chem. 237, 1622–1625 (1962).
Lucas, Z.J.: Pyrimidine nucleotide synthesis: Regulatory control during transformation of lymphocytes in vitro. Science 156, 1237–1240 (1967).
Maddy, A.H.: The properties of the protein of the plasma membrane of ox erythrocytes. Biochim. biophys. Acta (Amst.) 117, 193–200 (1966).
Martin, K.: Concentrative accumulation of choline by human erythrocytes. J. gen. Physiol. 51, 497–516 (1968).
Marzulli, F.N., Callahan, J.F., Brown, D.W.C.: Chemical structure and skin penetrating capacity of a short series of organic phosphates and phosphoric acid. J. invest. Dermatol. 44, 339–344 (1965).
McGuire, W.L., Julian, J. A.: Comparison of macromolecular binding of estradiol in hormone-dependent and hormone-independent rat mammary carcinoma. Cancer Res. 31, 1440–1445 (1971).
Mobbs, B.G.: The uptake of tritiated estradiol by 9, 10-dimethyl-1, 2-benzanthracene-induced mammary tumors of the rat. J. Endocrinol. 36, 409–414 (1966).
Montgomery, J.A., Dixon, G. J., Dulmage, E.A., Thomas, H.J., Brockman, R.W., Skipper, H.E.: Inhibition of 6-mercaptopurine-resistant cancer cells in culture by bis(thioinosine) 5′, 5″-phosphate. Nature (Lond.) 199, 769–772 (1963).
Nahas, A., Nixon, P.F., Bertino, J.R.: Uptake of 5-formyltetrahydrofolate by L1210 mouse leukemia cells and its effect on uptake of methotrexate. Proc. Amer. Assoc. Cancer Res. 10, 64 (1969).
Nakata, Y., Bader, J.P.: The uptake of nucleosides by cells in culture. II. Inhibition by 2-mercapto-l-(β-4-pyridethyl)benzimidazole. Biochim. biophys. Acta (Amst.) 190, 250–256 (1969).
Oliver, J.M., Paterson, A.R.P.: Nucleoside transport. I. A mediated process in human erythrocytes. Canad. J. Biochem. 49, 262 (1971).
Overgaard-Hansen, K., Lassen, U.V.: Active transport of uric acid through the human erythrocyte membrane. Nature (Lond.) 184, 553–554 (1959).
Overman, J.R.: Ingestion of latex particles by chicken fibroblasts in tissue culture. Proc. Soc. exp. Biol. Med. 107, 895–900 (1961).
Parpart, A.K., Ballentine, R.: Molecular anatomy of red cell membrane. In: Modern trends in physiology and biochemistry. New York: Academic Press 1952.
Paterson, A.R.P.: Resistance to 6-mercaptopurine II. The synthesis of thioinosinic acid in a resistant subline of the Ehrlich ascites carcinoma. Canad. J. Biochem. 40, 195–206 (1962).
Paterson, A.R.P., Oliver, J.M.: Nucleoside transport II. Inhibition by p-nitrobenzylthio-guanosine and related compounds. Canad. J. Biochem. 49, 271–274 (1971).
Paterson, A.R.P., Simpson, A.I.: Inhibitors of nucleoside metabolism. Canad. J. Biochem. 44, 1423–1433 (1966).
Penniston, J.T., Beckett, L., Bentley, D.L., Hansch, C.: Passive permeation of organic compounds through biological tissue: A nonsteady state theory. Molec. Pharmacol. 5, 333–341 (1969).
Plagemann, P.G.W.: Nucleoside transport by Novikoff rat hepatoma cells growing in suspension culture. Specificity and mechanism of transport reactions and relationship to nucleoside incorporation into nucleic acids. Biochim. biophys. Acta (Amst.) 233, 688–701 (1971).
Plagemann, P.G. W., Roth, M. F.: Permeation as the rate limiting step in the phosphorylation of uridine and choline and their incorporation in macromolecules by Novikoff hepatoma cells. Competitive inhibition by phenethyl alcohol, persantin and adenosine. Biochem. 8, 4782–4789 (1969).
Plagemann, P.G.W., Ward, G.A., Mahy, B.W.J., Korbecki, M.: Relationship between uridine kinase activity and rate of incorporation of uridine into acid soluble pool and into RNA during growth cycle of rat hepatoma cells. J. cell. Physiol. 73, 233–250 (1969).
Plunkett, W., Lapi, L., Ortiz, P., Cohen, S.S.: Cellular penetration and metabolism of 9-β-D-arabinofuranosyl adenine 5’-monophosphate (araAMP). Proc. Am. Ass. Cancer Res. 14, 32 (1973).
Potter, L.T.: Uptake of choline by nerve endings isolated from the rat cerebral cortex. In: Campbell, P.N. (Ed.): The interaction of drugs and subcellular components in animal cells, p. 293. Boston: Little, Brown and Co. 1968.
Puca, G.A., Nola, E., Sica, V., Bresciani, F.: Estrogen-binding proteins of calf uterus. Partial purification and preliminary characterization of two cytoplasmic proteins. Biochemistry 10, 3769–3780 (1971).
Roberts, D.W.: Cleavage of folic acid by hydrogen peroxide. Biochim. biophys. Acta (Amst.) 54, 572–574 (1961).
Roll, P.M., Weinfeld, H., Carroll, E., Brown, G.B.: The utilization of nucleotides by the mammal IV. Triply labeled purine nucleotides. J. biol. Chem. 220, 439–454 (1956).
Rosenbloom, F.M., Kelley, W.N., Henderson, J.F., Seegmiller, J.E.: Lyon hypothesis and X-linked disease. Lancet 2, 305–306 (1967).
Rothblat, G.H., Buchko, M.K., Rritchevsky, D.: Cholesterol uptake by L5178Y cells: Studies with delipidized serum. Biochim. biophys. Acta (Amst.) 164, 327–338 (1968).
Rubin, R.C., Henderson, E.S., Owens, E.S., Rall, D.P.: Uptake of methotrexate-H3 by rabbit kidney slices. Cancer Res. 27, 553–557 (1967).
Ryan, W.L., Heidrick, M.L.: Inhibition of cell growth in vitro by adenosine 3′, 5′-monophosphate. Science 162, 1484–1485 (1968).
Ryser, H.J.P., Hancock, R.: Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150, 501–503 (1965).
Sartorelli, A.C., Iannotti, A.L., Booth, B.A., Schneider, F.H., Bertino, J.R., Johns, D.G.: Complex formation with DNA and inhibition of nucleic acid synthesis by methyl-glyoxal bis(guanylhydrazone). Biochim. biophys. Acta (Amst.) 103, 174–176 (1965).
Schanker, L.S., Jeffrey, J.J.: Active transport of foreign pyrimidines across the intestinal epithelium. Nature (Lond.) 190, 727–728 (1961).
Schanker, L.S., Jeffrey, J.J.: Structural specifity of the pyrimidine transport process of the small intestine. Biochem. Pharmacol. 11, 961–966 (1962).
Schanker, L.S., Jeffrey, J.J., Tocco, D.J.: Interaction of purines with the pyrimidine transport process of the small intestine. Biochem. Pharmacol. 12, 1047–1053 (1963).
Schanker, L.S., Tocco, D.J.: Active transport of some pyrimidines across the rat intestinal epithelium. J. Pharmacol, exp. Ther. 28, 115–121 (1960).
Schanker, L.S., Tocco, D. J.: Some characteristics of the pyrimidine transport process of the small intestine. Biochim. biophys. Acta (Amst.) 56, 469–473 (1962).
Schröder, J., Plagemann, P.G.W.: Growth of Novikoff rat hepatoma cells in suspension culture in the presence of adenosine 3′, 5′-cyclic monophosphate. J. Natl. Cancer Inst. 46, 423–429 (1971).
Schuberth, J., Sundwall, A., Sorbo, B.: Relation between Na+-K+ transport and the up-take of choline by brain slices. Life Sci. 6, 293–295 (1967).
Schuberth, J., Sundwall, A., Sörbo, B., Lindell, J.O.: Uptake of choline by mouse brain slices. J. Neurochem. 13, 347–352 (1966).
Singer, S., Litwack, G.: Identity of corticosteroid binder I with the macromolecule binding 3-methyl cholanthrene in liver cytosol in vivo. Cancer Res. 31, 1364–1368 (1971).
Sirotnak, F.M., Kurita, S., Hutchison, D.J.: On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia. Cancer Res. 28, 75–80 (1968)
Smith, C.G., Reineke, L.M., Burch, M.R., Shefner, A.M., Muirhead, E.E.: Studies on up-take of tubercidin by blood cells and its distribution in whole animals. Cancer Res. 30, 69–75 (1970).
Song, C.S., Kappas, A., Bodansky, O.: 5′-NucIeotidase of plasma membranes of the rat liver: Studies on subcellular distribution. Ann. N. Y. Acad. Sci. 166, 565–573 (1969).
Steggles, A.W., King, R.J.B.: The uptake of [6, 7-3H] oestradiol by estrogen dependent and independent hamster kidney tumors. Eur. J. Cancer 4, 395–401 (1968).
Sung, C.P., Johnstone, R.M.: Evidence for active transport of choline in rat kidney cortex slices. Canad. J. Biochem. 43, 1111–1118 (1965).
Suolinna, E.M., Tritsch, G., Hakala, M.T.: Asparagine and glutamine metabolism in Sarcoma 180 cells in vitro. Proc. Amer. Ass. Cancer Res. 12, 29 (1971).
Tan, K.B., Mcauslan, B.R.: Inhibition of nucleoside incorporation into Hela cells by streptovaricin. Biochem. biophys. Res. Comm. 42, 230–236 (1971).
Vandevoorde, J.P., Hansen, H.J.: Inhibition of J 128 cell culture by 6-mercaptopurine and 9-alkylated derivatives of 6-mercaptopurine. Proc. Amer. Ass. Cancer Res. 8, 70 (1967).
Wartiovaara, V., Collander, R.: Permeabilitätstheorien. In: Protoplasmatologia: Handbuch der Protoplasmaforschung, vol. II, C. 8d. Vienna: Springer 1960.
Weiss, L., Hakala, M.T.: The anionic nature of Sarcoma 180 cell surfaces, and sensitivity to 4,4′-diacetyl-diphenyl-urea-bis-guanylhydrazone. Cancer Res. 31, 1369–1372 (1971).
Werkheiser, W.C.: Specific binding of 4-amino folic acid analogues by folic acid reductase. J. biol. Chem. 236, 888–893 (1961).
Wilson, T.H., Wdlson, D.W.: Intestinal absorption in vitro of uridylic and thymidylic acids. Biochim. biophys. Acta (Amst.) 22, 587 (1956)
Wilson, T.H., Wdlson, D.W.: Intestinal absorption in vitro of uridylic and thymidylic acids. J. Physiol. 123, 116 (1954).
Wilson, T.H., Wilson, D.W.: Studies in vitro of digestion and absorption of pyrimidine nucleotides by the intestine. J. biol. Chem. 233, 1544–1547 (1958).
Wolpert, M.K., Ruddon, R. W.: A study on the mechanism of resistance to nitrogen mustard (HN2) in Ehrlich ascites tumor cells: Comparison of uptake of HN2-14C into sensitive and resistant cells. Cancer Res. 29, 873–879 (1969).
Yamada, T., Iwanami, Y., Baba, T.: The transport of 14C-labeled nitrogen mustard N-oxide through cellular membrane treated with Tween-80 in vitro. Garni 54, 171–176 (1963).
Yesair, D.W., Kohner, F.A., Rogers, W.I., Baronowsky, P.E., Kensler, C.J.: Relationship of phthalanilide-lipid complexes to uptake and retention of 2-chloro-4′, 4″-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by sensitive and resistant P388 leukemia cells. Cancer Res. 26, 202–207 (1966).
Yesair, D.W., Rogers, W.I., Baronowsky, P.E., Wodinsky, I., Thayer, P.S., Kensler, C.J.: Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells. Cancer Res. 27, 314–321 (1967).
Zakrzewski, S.F.: The mechanism of binding of folate analogues by folate reductase. J. biol. Chem. 238, 1485–1490 (1963a).
Zakrzewski, S.F.: Relationship between basicity of certain folate analogues and their affinities for folate reductase. J. biol. Chem. 238, 4002–4004 (1963b).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hakala, M.T. (1974). Transport of Antineoplastic Agents. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive